Pear Therapeutics Inc:企業の製品パイプライン分析2018

◆英語タイトル:Pear Therapeutics Inc - Product Pipeline Analysis, 2018 Update
◆商品コード:DATA904C12777
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥84,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥168,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥252,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pear Therapeutics Inc (Pear Therapeutics) develops software-based prescription digital therapeutics for the treatment of severe medical conditions and diseases. Its product pipeline includes reSET-O for treating opioid use disorder (OUD) in conjunction with opioid replacement therapy; Thrive designed for schizophrenia; reCALL using virtual reality exposure therapy to treat combat posttraumatic stress disorder (PTSD); reVIVE against general anxiety disorder; and PEAR-005 to PEAR-011 for treating pain, major depressive disorder, insomnia, Parkinson’s disease and inflammatory conditions. Pear Therapeutics reSET, is an FDA-authorized prescription therapeutic for substance use disorder (SUD) used as an outpatient treatment. The company works in partnership with Center for Technology and Behavioral Health, Dartmouth College, Ehave, Inc., Intellectual Ventures Management LLC, Novartis AG, and others. Pear Therapeutics is headquartered in Boston, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Pear Therapeutics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Pear Therapeutics Inc Company Overview 5
Pear Therapeutics Inc Company Snapshot 5
Pear Therapeutics Inc Pipeline Products and Ongoing Clinical Trials Overview 5
Pear Therapeutics Inc – Pipeline Analysis Overview 8
Pear Therapeutics Inc – Key Facts 8
Pear Therapeutics Inc – Major Products and Services 9
Pear Therapeutics Inc Pipeline Products by Development Stage 11
Pear Therapeutics Inc Ongoing Clinical Trials by Trial Status 13
Pear Therapeutics Inc Pipeline Products Overview 15
Digital Therapeutic – Inflammatory conditions 15
Digital Therapeutic – Inflammatory conditions Product Overview 15
Digital Therapeutic – Major Depressive Disorder 16
Digital Therapeutic – Major Depressive Disorder Product Overview 16
Digital Therapeutic – Oncology 17
Digital Therapeutic – Oncology Product Overview 17
Digital Therapeutic – Parkinson’s Disease 18
Digital Therapeutic – Parkinson’s Disease Product Overview 18
Digital Therapeutic – Respiratory 19
Digital Therapeutic – Respiratory Product Overview 19
PEAR-003 – Insomnia 20
PEAR-003 – Insomnia Product Overview 20
PEAR-006 – Multiple Sclerosis 21
PEAR-006 – Multiple Sclerosis Product Overview 21
reCALL 22
reCALL Product Overview 22
reVIVE 23
reVIVE Product Overview 23
Thrive 24
Thrive Product Overview 24
Thrive Clinical Trial 25
Pear Therapeutics Inc – Key Competitors 26
Pear Therapeutics Inc – Key Employees 27
Pear Therapeutics Inc – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Pear Therapeutics Inc, Recent Developments 29
Jan 16, 2018: Magellan Health Continues Innovation and Efforts to Improve Outcomes for Patients with Substance Use Disorder 29
Dec 12, 2017: Pear Therapeutics Wins Fierce Innovation Life Science Award for reSET Prescription Digital Therapeutic 29
Oct 18, 2017: Pear Therapeutics Receives Expedited Access Pathway Designation from FDA for reSET-O Prescription Digital Therapeutic to Treat Opioid Use Disorder 30
Sep 26, 2017: Pear Therapeutics Selected to Participate in the FDA’s Digital Health Software Pre-Cert Pilot Program 30
Sep 14, 2017: FDA permits marketing of mobile medical application for substance use disorder 31
Sep 14, 2017: Pear Therapeutics Obtains FDA Clearance Of The First Prescription Digital Therapeutic To Treat Disease 31
Jul 11, 2017: Enhancing Digital Medicine to Tackle Addiction 32
Aug 25, 2016: The Largest and Longest Study of Patients with Schizophrenia Interacting with Digital Therapeutics Results Released 33
Appendix 34
Methodology 34
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Pear Therapeutics Inc Pipeline Products and Ongoing Clinical Trials Overview 5
Pear Therapeutics Inc Pipeline Products by Equipment Type 6
Pear Therapeutics Inc Pipeline Products by Indication 7
Pear Therapeutics Inc Ongoing Clinical Trials by Trial Status 7
Pear Therapeutics Inc, Key Facts 8
Pear Therapeutics Inc, Major Products and Services 9
Pear Therapeutics Inc Number of Pipeline Products by Development Stage 11
Pear Therapeutics Inc Pipeline Products Summary by Development Stage 12
Pear Therapeutics Inc Ongoing Clinical Trials by Trial Status 13
Pear Therapeutics Inc Ongoing Clinical Trials Summary 14
Digital Therapeutic - Inflammatory conditions - Product Status 15
Digital Therapeutic - Inflammatory conditions - Product Description 15
Digital Therapeutic - Major Depressive Disorder - Product Status 16
Digital Therapeutic - Major Depressive Disorder - Product Description 16
Digital Therapeutic - Oncology - Product Status 17
Digital Therapeutic - Oncology - Product Description 17
Digital Therapeutic - Parkinson's Disease - Product Status 18
Digital Therapeutic - Parkinson's Disease - Product Description 18
Digital Therapeutic - Respiratory - Product Status 19
Digital Therapeutic - Respiratory - Product Description 19
PEAR-003 - Insomnia - Product Status 20
PEAR-003 - Insomnia - Product Description 20
PEAR-006 - Multiple Sclerosis - Product Status 21
PEAR-006 - Multiple Sclerosis - Product Description 21
reCALL - Product Status 22
reCALL - Product Description 22
reVIVE - Product Status 23
reVIVE - Product Description 23
Thrive - Product Status 24
Thrive - Product Description 24
Thrive - A Randomized, Sham-controlled Study of PEAR-004 as an Adjunct to Standard-of-care Treatment for Schizophrenia 25
Pear Therapeutics Inc, Key Employees 27
Pear Therapeutics Inc, Other Locations 28
Glossary 36

List of Figures
Pear Therapeutics Inc Pipeline Products by Equipment Type 6
Pear Therapeutics Inc Pipeline Products by Development Stage 11
Pear Therapeutics Inc Ongoing Clinical Trials by Trial Status 13

★海外企業調査レポート[Pear Therapeutics Inc:企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Telconet S.A.:企業の戦略的SWOT分析
    Telconet S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Mission Pharmacal Company:企業概要及び戦略的SWOT分析
    Mission Pharmacal Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Polylite Taiwan Co., Ltd. (1813):企業の財務及び戦略的SWOT分析
    Summary Polylite Taiwan Co., Ltd. (Polylite) is a medical device company that manufactures ophthalmic lens. The company manufactures and distributes GIA polycarbonate lenses. Its products include GIA FSV lens, GIA SFSV lens, GIA Progressive lens, GIA Kids lens and GIA Polarized lens lens. Polylite’s …
  • Adelaide Resources Limited (ADN):企業の財務及び戦略的SWOT分析
    Summary Adelaide Resources Limited (Adelaide) is a mineral exploration company that provides gold and copper deposits. The company offers risk managed discovery, development and mining opportunity services. It offers mineral discovery covering a range of commodities including gold, copper-gold, mine …
  • MILEI GmbH: Ingredients:企業概要およびSWOT分析
    Summary Canadean's "MILEI GmbH: Ingredients - Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, key emp …
  • Health Care Service Corporation:企業の戦略・SWOT・財務分析
    SummaryHealth Care Service Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the comp …
  • PetroVietnam Exploration Production Corporation:企業のM&A・提携動向(石油・ガス分野)
    Summary PetroVietnam Exploration Production Corporation (PVEP), a subsidiary of Vietnam Oil and Gas Group is an oil and gas company that carries out the exploration and production of oil and gas assets. The company’s projects include Red River Basin, Phu Khanh Basin, Cuu Long Basin, Nam Con Son Basi …
  • Horne International, Inc.:企業の戦略・SWOT・財務分析
    SummaryHorne International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. K …
  • Chimimport AD:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Chimimport AD Mergers and Acqui …
  • United Community Financial Corp.:企業の戦略・SWOT・財務分析
    SummaryUnited Community Financial Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the com …
  • Coffey International Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Coffey International Limited Me …
  • Southern Research Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Southern Research Institute (Southern Research) is an independent, non-profit, and scientific research organization that conducts research in the areas of preclinical drug development, advanced engineering, drug discovery, environmental protection, and others. The organization offers life sc …
  • Egyptian Financial and Industrial Company (EFIC):企業財務及び戦略的SWOT分析
    Summary Egyptian Financial and Industrial Company (EFIC) is a chemical company that offers phosphate fertilizer. The company manufactures phosphate fertilizer, sulphuric acid and other by-products. Its products include concentrated sulpheric acid, single super phosphate, compound nitrogen and phosph …
  • The Menarini Group:企業の戦略・SWOT・財務情報
    The Menarini Group - Strategy, SWOT and Corporate Finance Report Summary The Menarini Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Metso Corporation (MEO1V):企業のM&A・提携動向(発電分野)
    Summary Metso Corporation (Metso) is an industrial machinery company, which provides sustainable technology and services. It offers products such as mining and construction aggregates processing equipments, conveyers, separators, air classifiers, slurry pumps, industrial valves and controls, and was …
  • Emgesa SA ESP-エネルギー分野:企業M&A・提携分析
    Summary Emgesa SA ESP (Emgesa), a subsidiary of Enel, is an energy utility that generates and trades electricity. The company produces power from hydro, coal, and oil and gas; and procures energy from generator and trader agents in the wholesale market. It owns thermal stations: Cartagena and Martin …
  • Van Oord nv:企業のM&A・提携動向(エネルギー分野)
    Summary Van Oord nv (Van Oord) is a contracting company specialized in dredging, marine engineering and offshore projects including oil, gas and wind. The company's core activities include dredging, offshore oil and gas and offshore wind projects. Its major activities include creation of artificial …
  • HomeWorks Tri-County Electric Cooperative Inc:企業の戦略的SWOT分析
    HomeWorks Tri-County Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Galapagos NV:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Galapagos NV Mergers and Acquis …
  • Atlantic Airways P/F:戦略・SWOT・企業財務分析
    Atlantic Airways P/F - Strategy, SWOT and Corporate Finance Report Summary Atlantic Airways P/F - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆